PHILADELPHIA ― High-frequency deep transcranial magnetic stimulation (TMS) that targets signaling pathways involved in obsessive compulsive disorder (OCD) is showing promise as a novel approach for the treatment of this challenging disorder, new research shows.
“OCD unfortunately is a very disabling disorder for many of the people who have it, and about half of patients who have OCD are not able to recover adequately with currently approved treatments,” Aron Tendler, MD, chief medical officer of Brainsway, told Medscape Medical News.
“In this feasibility study, we were trying to figure out which stimulation parameter would be most effective — low-stimulation frequency, at 1 pulse per second, or high-stimulation frequency, at 20 pulses per second,” he added.
“We found a dramatic difference between the 20 pulses per second and the 1 pulse per second and between sham controls, so we now have an ongoing, multicenter study where we will be comparing the high-frequency 20-Hz stimulation to sham.”
Read the full article at: http://www.medscape.com/viewarticle/861650